# Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act:  Questions and Answers - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/labeling-of-nonprescription-human-drug-products-marketed-without-an-approved-application-as-required-by-the-dietary-supplement-and-nonprescription-drug-consumer-protection-act-questions-and-answers/ab547dc3-9724-4072-b1cd-f90728d300e3

> FDA guidance document: Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act:  Questions and Answers. Issue date: September 01, 2009. Get complete insights and analysis.

---

## Details

- Title: Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act:  Questions and Answers
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2009-09-01
- Last Changed: 2023-01-19
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2007-D-0429">FDA-2007-D-0429</a>

## Related Documents

- [Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application](https://www.globalkeysolutions.net/guidances/guidance-document/postmarketing-adverse-event-reporting-for-nonprescription-human-drug-products-marketed-without-an-approved-application/95170478-4748-49e7-88f5-b582dc43e2ee)
- [Radioactive Drug Research Committee: Human Research Without An Investigational New Drug Application](https://www.globalkeysolutions.net/guidances/guidance-document/radioactive-drug-research-committee-human-research-without-an-investigational-new-drug-application/f573b8cb-8d40-4beb-818f-4d2e16361206)
- [Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims](https://www.globalkeysolutions.net/guidances/guidance-document/hypertension-indication-drug-labeling-for-cardiovascular-outcome-claims/79efdd86-3643-466c-8fe3-82b6ad2e95ff)